Telephone
61.2.9432.9400
Address
Level 22 161 Castlereagh Street Liberty Place Sydney, New South Wales (NSW) 2000
Description
Healius Ltd. engages in the provision of healthcare technology solutions. It operates through the following segments: Pathology, Imaging, and Other. The Pathology segment provides pathology services. The Imaging segment focuses on imaging services from stand-alone imaging sites, hospitals, and medical centers. The Other segment consists of corporate functions. The company was founded by Edmund Gregory Thomas Bateman in 1985 and is headquartered in St. Leonards, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 1.08 - 1.86
Trade Value (12mth)
AU$823,099.00
1 week
-5.56%
1 month
3.03%
YTD
-2.51%
1 year
14.77%
All time high
9.10
EPS 3 yr Growth
-1358.10%
EBITDA Margin
19.90%
Operating Cashflow
$238m
Free Cash Flow Return
8.80%
ROIC
-23.70%
Interest Coverage
4.90
Quick Ratio
0.40
Shares on Issue (Fully Dilluted)
726m
HALO Sector
Healthcare
Next Company Report Date
21-Aug-25
Ex Dividend Date (est.)
07-Sep-22
Next Dividend Pay Date (est.)
21-Sep-22
Reporting Currency
AUD
Short Sell (% of issue)
3.63
Date | Announcements |
---|---|
27 March 25 |
Healius Investor Day 2025 - Investor Presentation
×
Healius Investor Day 2025 - Investor Presentation |
27 March 25 |
Healius Investor Day - webcast link
×
Healius Investor Day - webcast link |
24 March 25 |
Healius Investor Day
×
Healius Investor Day |
19 March 25 |
Change in substantial holding from PPT
×
Change in substantial holding from PPT |
03 March 25 |
Initial Director's Interest Notice - Neil Vinson
×
Initial Director's Interest Notice - Neil Vinson |
25 February 25 |
Change in substantial holding
×
Change in substantial holding |
25 February 25 |
Change in substantial holding from PPT
×
Change in substantial holding from PPT |
20 February 25 |
Half Yearly Report and Accounts
×
Half Yearly Report and Accounts |
20 February 25 |
Half Year 2025 Results Presentation
×
Half Year 2025 Results Presentation |
20 February 25 |
Healius announces 1H 2025 results
×
Healius announces 1H 2025 results |
20 February 25 |
Board Changes and Company Secretary Resignation
×
Board Changes and Company Secretary Resignation |
18 February 25 |
Change in substantial holding from PPT
×
Change in substantial holding from PPT |
07 February 25 |
Change in substantial holding from PPT
×
Change in substantial holding from PPT |
28 January 25 |
Change of Director's Interest Notice
×
Change of Director's Interest Notice |
15 January 25 |
Webcast details for Healius HY 2025 Results
×
Webcast details for Healius HY 2025 Results |
02 December 24 |
Initial Director's Interest Notice
×
Initial Director's Interest Notice |
02 December 24 |
Final Director's Interest Notice
×
Final Director's Interest Notice |
29 November 24 |
Healius Board Changes
×
Healius Board Changes |
28 November 24 |
Change of Director's Interest Notice
×
Change of Director's Interest Notice |
25 November 24 |
Change of Director's Interest Notice
×
Change of Director's Interest Notice |
25 November 24 |
Change of Director's Interest Notice
×
Change of Director's Interest Notice |
25 November 24 |
Change of Director's Interest Notice
×
Change of Director's Interest Notice |
21 November 24 |
Change in substantial holding from PPT
×
Change in substantial holding from PPT |
20 November 24 |
Change in substantial holding
×
Change in substantial holding |
18 November 24 |
Becoming a substantial holder
×
Becoming a substantial holder |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.